MedTrace Logo

Transversus Abdominis Plane Blocks With Abdominoplasty

NCT01278264 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-04-27

No results posted yet for this study

Summary

Comparing morphine consumption and recovery with two different TAP block techniques after abdominoplasty.

Conditions

  • Post Operative Pain

Interventions

DRUG

Ropivacaine 0.25%, 0.5 ml/kg

Posterior approach for TAP: ultrasound guided bilateral needle insertion in the transversus abdominis plane, anterior to the quadratus lumborum muscle

DRUG

Ropivacaine 0.25%, 0.5 ml/kg

Subcostal approach for TAP: US guided needle insertion in the transversus abdominis plane, lateral to rectus sheet

Sponsors & Collaborators

  • Clinique Saint-Jean, Bruxelles

    lead OTHER

Principal Investigators

  • Arnaud G Bosteels, MD · Clinique Saint-Jean, Bruxelles

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-05-31
Completion
2012-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01278264 on ClinicalTrials.gov